Copyright
©The Author(s) 2025.
World J Gastrointest Surg. Feb 27, 2025; 17(2): 102342
Published online Feb 27, 2025. doi: 10.4240/wjgs.v17.i2.102342
Published online Feb 27, 2025. doi: 10.4240/wjgs.v17.i2.102342
Characteristic | Control (n = 63) | Observation (n = 64) | t/χ2 | P value |
Gender | - | - | 0.065 | 0.797 |
Male | 35 | 37 | - | - |
Female | 28 | 27 | - | - |
Age (years), mean ± SD | 44.27 ± 9.63 | 43.86 ± 9.87 | 0.236 | 0.813 |
BMI (kg/m²) | 23.59 ± 1.86 | 24.11 ± 1.74 | 1.627 | 0.106 |
Duration (years), mean ± SD | 2.65 ± 0.84 | 2.72 ± 0.81 | 0.478 | 0.633 |
Severity | - | - | 0.411 | 0.521 |
Mild | 25 | 29 | - | - |
Moderate | 38 | 35 | - | - |
- Citation: Yang CC, Zhang S, Zhang R, Zhao YN, Yang DW, Yang MY, Huang LJ. Application of Saccharomyces boulardii in combination with sulfasalazine in ulcerative colitis patients demonstrates significant effectiveness. World J Gastrointest Surg 2025; 17(2): 102342
- URL: https://www.wjgnet.com/1948-9366/full/v17/i2/102342.htm
- DOI: https://dx.doi.org/10.4240/wjgs.v17.i2.102342